|
Stocks
More News
Amicus Delays Filing
June 17, 2013
Amicus Therapeutics Inc. (Nasdaq: FOLD) will delay the approval filing for its Fabry disease treatment Amigal sending the stock price plummeting 65 cents to close at $2.54.... Read More
about
FOLD
Most Active Stocks
Full List
Gainers (% change)
Full List
|
Latest Tweets
Popular Stocks
Full List
|